Atacicept

  • Biologic
  • Trutakna

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Atacicept: storage and handling

Refrigerate
Yes, as the label states
Label statement
Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
Freezing
Do not freeze
Label statement
Do not freeze.
Room temperature
up to 3 days at or below 25°C (77°F)
Label statement
If needed, TRUTAKNA autoinjector may be stored at room temperature up to 25°C (77°F), for a single period of 3 days (72 hours).
Room temperature
up to 3 days at or below 25°C (77°F)
Label statement
If needed, TRUTAKNA may be stored at room temperature up to 77°F (25°C) for a single period of 3 days (72 hours).
Back into the refrigerator
Not allowed
Label statement
Once TRUTAKNA has been stored at room temperature, it should not be placed back into the refrigerator.
Light
Protect from light
Label statement
Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
Shaking
Do not shake
Label statement
Do not shake.

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (up to 3 days at up to 25°C (77°F)). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

If needed, TRUTAKNA autoinjector may be stored at room temperature up to 25°C (77°F), for a single period of 3 days (72 hours).
Once TRUTAKNA has been stored at room temperature, it should not be placed back into the refrigerator.
Discard the autoinjector if not used within this 72‑hour period.
Throw away (discard) TRUTAKNA autoinjector if not used within these 3 days (72 hours).

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1-833-633-8372 (the number printed on the label) about this product.

Where the label prints this number
If you have any questions about injecting TRUTAKNA, call Vera Therapeutics at 1-833-633-8372 or call your healthcare provider.
All storage statements on the label (19)
  • Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
  • If needed, TRUTAKNA autoinjector may be stored at room temperature up to 25°C (77°F), for a single period of 3 days (72 hours).
  • Once TRUTAKNA has been stored at room temperature, it should not be placed back into the refrigerator.
  • Discard the autoinjector if not used within this 72‑hour period.
  • Do not freeze.
  • Do not shake.
  • Do not expose to heat.
  • Storing TRUTAKNA Store TRUTAKNA in the refrigerator between 36°F and 46°F (2°C and 8°C).
  • Store TRUTAKNA in the original carton until time of use to protect it from light.
  • If needed, TRUTAKNA may be stored at room temperature up to 77°F (25°C) for a single period of 3 days (72 hours).
  • After TRUTAKNA has been stored at room temperature, it should not be placed back into the refrigerator.
  • Throw away (discard) TRUTAKNA autoinjector if not used within these 3 days (72 hours).
  • Do not freeze TRUTAKNA.
  • Do not shake TRUTAKNA.
  • Keep TRUTAKNA away from heat.
  • Bring the TRUTAKNA autoinjector to room temperature Remove one TRUTAKNA autoinjector from the refrigerator and allow it to sit for 15 to 30 minutes at room temperature between 60°F to 77°F (15°C to 25°C) before injecting.
  • Allowing the TRUTAKNA autoinjector to warm may make the injection more comfortable.
  • Do not microwave or heat up the TRUTAKNA autoinjector. 2.
  • Store TRUTAKNA in the refrigerator at 36°F to 46°F (2°C to 8°C).

FDA label version 3, effective August 5, 2026. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

No Part D formulary in the CMS files (2026Q3) lists this drug. It may be covered under Part B or not covered.

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.